Longitudinal studies across different ethnic groups have consistently identified low adiponectin as an independent predictor for T2D and NAFLD (Savvidou et al, 2009; Spranger et al, 2003). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.